b.harmony - for sensitive digestion, histamine intolerance, and a calmer gut.

In stock
Regular price
€59,00
Sale price
€59,00
Regular price
€59,00
Free shipping
Bottles
Bottles: single pack

✨ Designed for sensitive digestion

Suitable for individuals with histamine intolerance and celiac disease.
Lactose-free, gluten-free, and free from cow’s milk protein.

🧬 Scientifically documented probiotic strains

Sustainably increases levels of Lactobacillus and Bifidobacterium in the gut.

🌱 Enhanced with omega-3

Omega-3 fatty acids improve probiotic activity and colonization.

 

What it does

  • Provides beneficial probiotic bacteria to support balanced digestion.
  • Increases the abundance of Lactobacillus and Bifidobacterium—two key genera linked to smoother digestive function.
  • Supports microbial resilience thanks to omega-3 fatty acids, which help probiotics colonize more effectively and stay active longer.
  • Contributes natural anti-inflammatory effects through EPA and DHA.
  • Survives stomach acid & bile

The probiotic strains in b.harmony are tested for resistance to gastric acid and bile.
They reach the intestines alive and functional, even if the capsule dissolves earlier during digestion.

Capsules can be safely opened and mixed with a beverage if swallowing is difficult.

 

Ingredients (per daily dose):

Bifidobacterium animalis lactis B1 – 3.33 x 10⁹ CFU

Bifidobacterium breve BL10 – 3.33 x 10⁹ CFU

Bifidobacterium breve Bbr8 – 3.33 x 10⁹ CFU

Lactobacillus paracasei 101/37 – 5 x 10⁹ CFU

Lactiplantibacillus plantarum 14D – 5 x 10⁹ CFU

Omega-3 fatty acids (EPA) – 136 mg

Omega-3 fatty acids (DHA) – 72 mg

Other fatty acids – 64 mg

L-lysine (amino acid) – 128 mg

 

Packaging leaflet

MVDr. Alojz Bomba, DrSc.

At the heart of Beie.’s innovation stands MVDr. Alojz Bomba, DrSc., co-founder and Chief Scientific Officer of PerBiotiX, and former head of Experimental Medicine at Pavol J. Šafárik University in Košice. With over 40 years of microbiome research, he pioneered the concept of targeted modulation of gut microbiota—a methodology now published and cited internationally. Prof. Bomba led major EU-funded projects studying probiotic and bioactive substances aimed at preventing conditions such as inflammatory bowel diseases, cancer, allergies, and metabolic disorders. He’s also the founder of the International Probiotics & Prebiotics Conference—one of the largest global gatherings of microbiome scientists.